Table 2.
Demographic and clinicopathological characteristics of patients
| Parameters | PTC | FTC | MNG | Total |
|---|---|---|---|---|
| Patients number | 28 | 9 | 27 | 64 |
| Gender | ||||
| Male | 2 (7.1) | 4 (50) | 8 (29.6) | 14 (22.2) |
| Female | 26 (92.9) | 4 (50) | 19 (70.4) | 49 (77.8) |
| Age (years) | ||||
| < 45 | 21 (75) | 3 (37.5) | 8 (29.6) | 32 (50.8) |
| ≥ 45 | 7 (25) | 5 (62.5) | 19 (70.4) | 31 (49.2) |
| BRAF V600E mutation | ||||
| Positive | 12 (46.2) | 2 (22.2) | – | – |
| Negative | 14 (53.8) | 7 (77.8) | – | – |
| Tumor size (cm) | ||||
| < 2 | 13 (46.4) | 2 (25) | – | – |
| ≥ 2 | 15 (53.6) | 6 (75) | – | – |
| Extrathyroidal extension | ||||
| Positive | 4 (14.8) | 3 (42.9) | – | – |
| Negative | 23 (85.2) | 4 (57.1) | – | – |
| Extracapsular invasion | ||||
| Positive | 4 (14.8) | 3 (42.9) | – | – |
| Negative | 23 (85.2) | 4 (57.1) | – | – |
| Lymph node metastasis | ||||
| Positive | 8 (29.6) | 1 (14.3) | – | – |
| Negative | 19 (70.4) | 6 (85.7) | – | – |
| Blood vascular invasion | ||||
| Positive | 4 (14.8) | 2 (71.4) | ||
| Negative | 23 (85.2) | 5 (28.6) | ||
| TNM stage (AJCC) | ||||
| I and II | 23 (82.1) | 4 (57.1) | – | – |
| III and IV | 5 (17.9) | 3 (42.9) | – | – |
PTC papillary thyroid cancer, FTC follicular thyroid cancer, MNG multinodular goiter, AJCC American Joint Committee on Cancer